Crohn's disease is a chronic inflammatory condition that can affect any part of the digestive tract, from the mouth to the anus. It often causes abdominal pain, diarrhea, and fatigue, and can significantly impact a person's quality of life. While the exact cause is unknown, it's thought to involve an abnormal immune response, and it typically affects young adults.
Crohn's disease is a chronic, transmural inflammatory disorder of the gastrointestinal tract, characterized by skip lesions and granulomatous inflammation. It can affect any segment from the oral cavity to the anus, with the terminal ileum and colon being most commonly involved. The etiology is multifactorial, involving genetic predisposition, environmental factors, gut microbiota dysbiosis, and dysregulated immune responses.
| Condition | Distinguishing Feature |
|---|---|
| Ulcerative Colitis | Typically limited to the colon, continuous inflammation starting from the rectum, superficial mucosal involvement, absence of skip lesions and transmural inflammation. |
| Infectious Colitis (e.g., C. difficile, Salmonella) | Acute onset, often associated with recent antibiotic use or contaminated food/water, usually self-limiting or responsive to specific antimicrobial therapy. |
| Irritable Bowel Syndrome (IBS) | Absence of objective inflammatory markers, no weight loss or bleeding (typically), diagnosis of exclusion based on Rome criteria. |
| Appendicitis | Acute onset, localized right lower quadrant pain migrating from periumbilical area, fever, leukocytosis, usually resolves with appendectomy. |
| Malignancy (e.g., Colorectal Cancer) | Progressive symptoms, often in older individuals, presence of a mass on imaging, positive fecal occult blood test, biopsy confirmation. |
| Tuberculosis (Intestinal) | Can mimic Crohn's, especially in endemic areas; consider if travel history, weight loss, fever, and granulomas on biopsy. |
Management is individualized and aims to induce and maintain remission, improve quality of life, and prevent complications. Treatment strategies include medical therapy (5-ASA agents, corticosteroids, immunomodulators, biologics) and nutritional support, with surgical intervention reserved for complications or refractory disease.